These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

705 related items for PubMed ID: 21435608

  • 1. 5-year follow-up of polytetrafluoroethylene-covered stents compared with bare-metal stents in aortocoronary saphenous vein grafts the randomized BARRICADE (barrier approach to restenosis: restrict intima to curtail adverse events) trial.
    Stone GW, Goldberg S, O'Shaughnessy C, Midei M, Siegel RM, Cristea E, Dangas G, Lansky AJ, Mehran R.
    JACC Cardiovasc Interv; 2011 Mar; 4(3):300-9. PubMed ID: 21435608
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Outcomes with drug-eluting versus bare-metal stents in saphenous vein graft intervention results from the STENT (strategic transcatheter evaluation of new therapies) group.
    Brodie BR, Wilson H, Stuckey T, Nussbaum M, Laurent S, Bradshaw B, Humphrey A, Metzger C, Hermiller J, Krainin F, Juk S, Cheek B, Duffy P, Simonton CA, STENT Group.
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1105-12. PubMed ID: 19926052
    [Abstract] [Full Text] [Related]

  • 4. Clinical presentation and angiographic characteristics of saphenous vein graft failure after stenting: insights from the SOS (stenting of saphenous vein grafts) trial.
    Lichtenwalter C, de Lemos JA, Roesle M, Obel O, Holper EM, Haagen D, Saeed B, Iturbe JM, Shunk K, Bissett JK, Sachdeva R, Voudris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger P, Banerjee S, Brilakis ES.
    JACC Cardiovasc Interv; 2009 Sep; 2(9):855-60. PubMed ID: 19778774
    [Abstract] [Full Text] [Related]

  • 5. A randomized trial of polytetrafluoroethylene-membrane-covered stents compared with conventional stents in aortocoronary saphenous vein grafts.
    Schächinger V, Hamm CW, Münzel T, Haude M, Baldus S, Grube E, Bonzel T, Konorza T, Köster R, Arnold R, Haase J, Probst P, vom Dahl J, Neumann FJ, Mudra H, Hennen B, Thiele L, Zeiher AM, STENTS (STents IN Grafts) Investigators.
    J Am Coll Cardiol; 2003 Oct 15; 42(8):1360-9. PubMed ID: 14563575
    [Abstract] [Full Text] [Related]

  • 6. Outcomes after implantation of the TAXUS paclitaxel-eluting stent in saphenous vein graft lesions: results from the ARRIVE (TAXUS Peri-Approval Registry: A Multicenter Safety Surveillance) program.
    Brilakis ES, Lasala JM, Cox DA, Berger PB, Bowman TS, Starzyk RM, Dawkins KD.
    JACC Cardiovasc Interv; 2010 Jul 15; 3(7):742-50. PubMed ID: 20650436
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial.
    Vermeersch P, Agostoni P, Verheye S, Van den Heuvel P, Convens C, Van den Branden F, Van Langenhove G, DELAYED RRISC (Death and Events at Long-term follow-up AnalYsis: Extended Duration of the Reduction of Restenosis In Saphenous vein grafts with Cypher stent) Investigators.
    J Am Coll Cardiol; 2007 Jul 17; 50(3):261-7. PubMed ID: 17631219
    [Abstract] [Full Text] [Related]

  • 9. Seven-year safety and efficacy of the unrestricted use of drug-eluting stents in saphenous vein bypass grafts.
    Nauta ST, Van Mieghem NM, Magro M, Deckers JW, Simsek C, Van Geuns RJ, Van Der Giessen WJ, De Jaegere P, Regar E, Van Domburg RT, Serruys PW.
    Catheter Cardiovasc Interv; 2012 May 01; 79(6):912-8. PubMed ID: 21542111
    [Abstract] [Full Text] [Related]

  • 10. Stent-Only Versus Adjunctive Balloon Angioplasty Approach for Saphenous Vein Graft Percutaneous Coronary Intervention: Insights From DIVA Trial.
    Latif F, Uyeda L, Edson R, Bhatt DL, Goldman S, Holmes DR, Rao SV, Shunk K, Aggarwal K, Uretsky B, Bolad I, Ziada K, McFalls E, Irimpen A, Truong HT, Kinlay S, Papademetriou V, Velagaleti RS, Rangan BV, Mavromatis K, Shih MC, Banerjee S, Brilakis ES.
    Circ Cardiovasc Interv; 2020 Feb 01; 13(2):e008494. PubMed ID: 32019343
    [Abstract] [Full Text] [Related]

  • 11. In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registry.
    Tolerico PH, Cohen DJ, Kleiman NS, Berger PB, Brilakis ES, Piana RN, Shammo S, Keyes MJ, Kennedy KF, Massaro JM, Saucedo JF, EVENT Investigators.
    Catheter Cardiovasc Interv; 2012 Dec 01; 80(7):1127-36. PubMed ID: 22431166
    [Abstract] [Full Text] [Related]

  • 12. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial.
    Vermeersch P, Agostoni P, Verheye S, Van den Heuvel P, Convens C, Bruining N, Van den Branden F, Van Langenhove G.
    J Am Coll Cardiol; 2006 Dec 19; 48(12):2423-31. PubMed ID: 17174178
    [Abstract] [Full Text] [Related]

  • 13. Follow-up results after interventional treatment of infarct-related saphenous vein graft occlusion.
    Hoffmann R, Nitendo G, Deserno V, Adamu U, Almalla M, Blindt R, Vogt F.
    Coron Artery Dis; 2010 Mar 19; 21(2):61-4. PubMed ID: 20124993
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Long term follow-up of drug eluting versus bare metal stents in the treatment of saphenous vein graft lesions.
    Ybarra LF, Ribeiro HB, Pozetti AH, Campos CA, Esper RB, Lemos PA, Lopes AC, Kalil-Filho R, Ellis SG, Ribeiro EE.
    Catheter Cardiovasc Interv; 2013 Dec 01; 82(7):E856-63. PubMed ID: 23239630
    [Abstract] [Full Text] [Related]

  • 17. A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions the SOS (Stenting of Saphenous Vein Grafts) trial.
    Brilakis ES, Lichtenwalter C, de Lemos JA, Roesle M, Obel O, Haagen D, Saeed B, Gadiparthi C, Bissett JK, Sachdeva R, Voudris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger P, Banerjee S.
    J Am Coll Cardiol; 2009 Mar 17; 53(11):919-28. PubMed ID: 19281920
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of a double-coated paclitaxel-eluting coronary stent: the EUCATAX trial.
    Rodriguez AE, Vigo CF, Delacasa A, Mieres J, Fernandez-Pereira C, Bernardi V, Bettinoti M, Rodriguez-Granillo AM, Rodriguez-Granillo G, Santaera O, Curotto V, Rubilar B, Tronge J, Palacios IF, Antoniucci D, EUCATAX Investigators.
    Catheter Cardiovasc Interv; 2011 Feb 15; 77(3):335-42. PubMed ID: 20824769
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of the slow-release polymer-based paclitaxel-eluting Taxus-Express stent with the bare-metal Express stent for saphenous vein graft interventions.
    Wöhrle J, Nusser T, Kestler HA, Kochs M, Hombach V.
    Clin Res Cardiol; 2007 Feb 15; 96(2):70-6. PubMed ID: 17146605
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.